A Small Nonerythropoietic Helix B Surface Peptide Based upon Erythropoietin Structure Is Cardioprotective against Ischemic Myocardial Damage
Ismayil Ahmet(National Institute on Aging), Mark I. Talan(National Institute on Aging), Michael Brines(Northwell Health), Hyun‐Jin Tae(Jeonbuk National University), Steven J. Sollott(National Institute on Aging), Daniel R. Riordon(National Institutes of Health), Edward G. Lakatta(Johns Hopkins University), Kenneth R. Boheler(National Institutes of Health), Magdalena Juhaszova(Institute on Aging), Anthony Cerami(Araim Pharmaceuticals (United States))
Cited by 55
Related Papers
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k
Elevated Aortic Pulse Wave Velocity, a Marker of Arterial Stiffness, Predicts Cardiovascular Events in Well-Functioning Older Adults
|Circulation|2005|1.2k
Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises
|Circulation|2003|1.1k
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
|Molecular Medicine|2002|1k
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
|Proceedings of the National Academy of Sciences|2001|1k